行业质量体系在药品CGMP法规方面的指导原则
VIP免费
Guidance for Industry
Quality Systems Approach to
Pharmaceutical CGMP Regulations
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Veterinary Medicine (CVM)
Office of Regulatory Affairs (ORA)
September 2006
Pharmaceutical CGMPs
Guidance for Industry
Quality Systems Approach to
Pharmaceutical CGMP Regulations
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm
or
Office of Communication, Training and
Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
1401 Rockville Pike, Rockville, MD 20852-1448
http://www.fda.gov/cber/guidelines.htm.
(Tel) 800-835-4709 or 301-827-1800
or
Communications Staff, HFV-12
Center for Veterinary Medicine
Food and Drug Administration
7519 Standish Place, Rockville, MD 20855
(Tel) 301-827-3800
http://www.fda.gov/cvm/guidance/published.html
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Veterinary Medicine (CVM)
Office of Regulatory Affairs (ORA)
September 2006
Pharmaceutical CGMP Regulations
Contains Nonbinding Recommendations
TABLE OF CONTENTS
I. INTRODUCTION............................................................................................................. 1
II. BACKGROUND AND PURPOSE.................................................................................. 1
A. Background ....................................................................................................................................1
B. Goal of the Guidance.....................................................................................................................2
C. Scope of the Guidance ...................................................................................................................3
D. Organization of this Guidance......................................................................................................4
III. CGMPS AND THE CONCEPTS OF MODERN QUALITY SYSTEMS................... 4
A. Quality.............................................................................................................................................4
B. Quality by Design and Product Development .............................................................................4
C. Quality Risk Management ............................................................................................................5
D. CAPA (Corrective and Preventive Action)..................................................................................5
E. Change Control..............................................................................................................................5
F. The Quality Unit ............................................................................................................................5
G. Six-system Inspection Model.........................................................................................................6
IV. THE QUALITY SYSTEMS MODEL............................................................................. 8
A. Management Responsibilities .......................................................................................................8
1. Provide Leadership..........................................................................................................................8
2. Structure the Organization ..............................................................................................................9
3. Build Your Quality System to Meet Requirements...........................................................................9
4. Establish Policies, Objectives, and Plans.....................................................................................10
5. Review the System..........................................................................................................................10
B. Resources......................................................................................................................................12
1. General Arrangements...................................................................................................................12
2. Personnel Development .................................................................................................................13
3. Facilities and Equipment...............................................................................................................13
4. Control Outsourced Operations ....................................................................................................14
C. Manufacturing .............................................................................................................................15
1. Design, Develop, and Document Product and Processes..............................................................15
2. Examine Inputs ..............................................................................................................................16
3. Perform and Monitor Operations..................................................................................................17
4. Address Nonconformities...............................................................................................................19
D. Evaluation Activities....................................................................................................................21
1. Analyze Data for Trends...............................................................................................................21
2. Conduct Internal Audits.................................................................................................................21
3. Quality Risk Management..............................................................................................................22
4. Corrective Action...........................................................................................................................22
摘要:
展开>>
收起<<
GuidanceforIndustryQualitySystemsApproachtoPharmaceuticalCGMPRegulationsU.S.DepartmentofHealthandHumanServicesFoodandDrugAdministrationCenterforDrugEvaluationandResearch(CDER)CenterforBiologicsEvaluationandResearch(CBER)CenterforVeterinaryMedicine(CVM)OfficeofRegulatoryAffairs(ORA)September2006Pharm...
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
ISO17025:2017一整套程序文件(实验室认可服务)VIP免费
2024-06-05 113 -
医疗器械工作程序文件VIP免费
2024-12-10 158 -
确认与验证管理规程VIP免费
2025-04-21 51 -
有害物质管理程序(含表格)VIP免费
2025-05-04 70 -
医疗器械上市后临床跟踪控制程序VIP免费
2025-10-27 46 -
供应商质量管理程序VIP免费
2025-11-07 64 -
DC2-07001 设备设施控制程序VIP免费
2026-03-21 10 -
DC2-07001 设备设施控制程序1VIP免费
2026-03-21 8 -
DC2-08001 与顾客有关的过程控制程序VIP免费
2026-03-21 6 -
DC2-09001 环境因素识别、评价与控制程序VIP免费
2026-03-21 12
作者:冒牌货
分类:专业资料
价格:60质量币
属性:32 页
大小:362.89KB
格式:PDF
时间:2025-12-04

